Saxenda is authorised in the UK for use for weight loss, together with diet and exercise
When the digestive tract is already compromised by ulceration or strictures, additional delays in stomach-to-intestine transit may worsen cramping, bloating, or obstruction risk
Great for users concerned about nutrient deficiencies on GLP-1s
Semaglutide extends beyond mere weight loss by enhancing crucial health indicators that mitigate the risk of chronic diseases like heart disease, stroke, and type 2 diabetes
Trial participants were randomised to receive either the higher 7.2mg dose of semaglutide, the currently approved 2.4mg dose, or placebo over 72 weeks
As research progresses, NAD+ supplementation could become a valuable tool in the quest for improved health and vitality